
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-03-02 | Stein Jeffrey | Director | Purchase | 50.0K | $32.96 | $1.65M | 54.3K | View ↗ |
No annual data found.
Assessing IDEAYA Biosciences (IDYA) Valuation After Positive Darovasertib Phase 2/3 Results And FDA Real-Time Review
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates
IDEAYA Biosciences GAAP EPS of -$1.11 misses by $0.12, revenue of $6.56M beats by $1.52M
IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update